Bacille Calmette-Guerin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG

Clinical Infectious Diseases

Volumn 22, Issue 5, 1996, Pages 870-871

  Van Deutekom, H ^a   Smulders, Y M ^b   Roozendaal, K J ^b   Van Soolingen, D ^b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL MENINGITIS; BCG VACCINATION; CANCER RISK; CASE REPORT; HOMOSEXUALITY; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; AIDS RELATED COMPLEX; ISOLATION AND PURIFICATION; MYCOBACTERIUM BOVIS; PATHOGENICITY; TIME; TUBERCULOUS MENINGITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BCG VACCINE; HUMANS; MALE; MYCOBACTERIUM BOVIS; TIME FACTORS; TUBERCULOSIS, MENINGEAL;

EID: 0029666133     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.5.870     Document Type: Article

References (5)

1. Weltman AC, Rose DN. The safety of bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS 1993;7:149-57.
2. Fomukong NG, Dale JW, Osborn TW, Grange JM. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol 1992;72:126-33.
3. Van Soolingen D, Hermans PWM, de Haas PEW, van Embden JDA. Insertion element IS1081-associated restriction fragment length polymorphism in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J Clin Microbiol 1992; 30:1772-7.
4. Li H, Ultrup JC, Jonassen TO, Melby K, Nagai S, Harboe M. Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun 1993;61:1730-4.
5. World Health Organization. Special programme on AIDS and expanded programme on immunization - joint statement: consultation on human immunodeficiency virus (HIV) and routine childhood immunization. Wkly Epidemiol Rec 1987;62:297-309.